Global Pharmatech Inc
Global Pharmatech, Inc., through its subsidiaries, discovers, develops, manufactures, and markets proprietary therapeutical products based on Traditional Chinese Medicine (TCM). The company was founded in 2001 and is based in Mong Kok, Hong Kong.
Global Pharmatech Inc (GBLP) - Cash Flow Conversion Efficiency
Latest cash flow conversion efficiency as of June 2025: -0.339x
Based on the latest financial reports, Global Pharmatech Inc (GBLP) has a cash flow conversion efficiency ratio of -0.339x as of June 2025.
Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow ($20.89K) by net assets ($-61.69K). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Global Pharmatech Inc - Cash Flow Conversion Efficiency Trend (2004–2024)
This chart illustrates how Global Pharmatech Inc's cash flow conversion efficiency has evolved over time, based on yearly financial data. Explore and compare other companies by cash flow conversion efficiency.
Global Pharmatech Inc Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Global Pharmatech Inc ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
CMG Cleantech S.A.
PA:MLCMG
|
N/A |
|
VINACONEX 21
VN:V21
|
N/A |
|
Glori Energy Technology Inc
PINK:GLRI
|
0.218x |
|
Remala Abadi Tbk.
JK:DATA
|
0.105x |
|
Jangada Mines Plc
LSE:JAN
|
-0.015x |
|
Indiabulls Enterprises Limited
NSE:IEL
|
N/A |
|
AlphaGen Intelligence Corp.
F:G4G
|
0.293x |
|
OCH.JSC
VN:OCH
|
N/A |
Annual Cash Flow Conversion Efficiency for Global Pharmatech Inc (2004–2024)
The table below shows the annual cash flow conversion efficiency of Global Pharmatech Inc from 2004 to 2024.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2024-12-31 | $-120.33K | $14.91K | -0.124x | -112.47% |
| 2023-12-31 | $-200.64K | $-199.27K | 0.993x | +149.84% |
| 2022-12-31 | $-196.45K | $391.44K | -1.993x | -256.71% |
| 2021-12-31 | $-49.26K | $-62.64K | 1.271x | +3132.23% |
| 2007-12-31 | $9.16 Million | $-383.94K | -0.042x | -294.02% |
| 2006-12-31 | $12.11 Million | $261.77K | 0.022x | +109.57% |
| 2005-12-31 | $8.24 Million | $-1.86 Million | -0.226x | -226.22% |
| 2004-12-31 | $6.53 Million | $1.17 Million | 0.179x | -- |